Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 58
Filtrar
2.
JAMA ; 329(19): 1637-1638, 2023 05 16.
Artículo en Inglés | MEDLINE | ID: mdl-37067806

RESUMEN

This Viewpoint outlines the progress made toward eliminating hepatitis B and C but emphasizes the work that remains to prioritize diagnosis and treatment of populations disproportionately affected by viral hepatitis, including ensuring that there are systems in place to treat those infected and care for those at risk.


Asunto(s)
Disparidades en el Estado de Salud , Disparidades en Atención de Salud , Hepatitis Viral Humana , Humanos , Disparidades en Atención de Salud/etnología , Disparidades en Atención de Salud/estadística & datos numéricos , Hepatitis Viral Humana/epidemiología , Hepatitis Viral Humana/etnología , Hepatitis Viral Humana/etiología , Hepatitis Viral Humana/terapia , Estados Unidos/epidemiología
5.
J Med Internet Res ; 22(10): e23173, 2020 10 23.
Artículo en Inglés | MEDLINE | ID: mdl-33095177

RESUMEN

BACKGROUND: AIDSVu is a public resource for visualizing HIV surveillance data and other population-based information relevant to HIV prevention, care, policy, and impact assessment. OBJECTIVE: The site, AIDSVu.org, aims to make data about the US HIV epidemic widely available, easily accessible, and locally relevant to inform public health decision making. METHODS: AIDSVu develops visualizations, maps, and downloadable datasets using results from HIV surveillance systems, other population-based sources of information (eg, US Census and national probability surveys), and other data developed specifically for display and dissemination through the website (eg, pre-exposure prophylaxis [PrEP] prescriptions). Other types of content are developed to translate surveillance data into summarized content for diverse audiences using infographic panels, interactive maps, local and state fact sheets, and narrative blog posts. RESULTS: Over 10 years, AIDSVu.org has used an expanded number of data sources and has progressively provided HIV surveillance and related data at finer geographic levels, with current data resources providing HIV prevalence data down to the census tract level in many of the largest US cities. Data are available at the county level in 48 US states and at the ZIP Code level in more than 50 US cities. In 2019, over 500,000 unique users consumed AIDSVu data and resources, and HIV-related data and insights were disseminated through nearly 4,000,000 social media posts. Since AIDSVu's inception, at least 249 peer-reviewed publications have used AIDSVu data for analyses or referenced AIDSVu resources. Data uses have included targeting of HIV testing programs, identifying areas with inequitable PrEP uptake, including maps and data in academic and community grant applications, and strategically selecting locations for new HIV treatment and care facilities to serve high-need areas. CONCLUSIONS: Surveillance data should be actively used to guide and evaluate public health programs; AIDSVu translates high-quality, population-based data about the US HIV epidemic and makes that information available in formats that are not consistently available in surveillance reports. Bringing public health surveillance data to an online resource is a democratization of data, and presenting information about the HIV epidemic in more visual formats allows diverse stakeholders to engage with, understand, and use these important public health data to inform public health decision making.


Asunto(s)
Visualización de Datos , Infecciones por VIH/prevención & control , Vigilancia en Salud Pública/métodos , Humanos
6.
AIDS Behav ; 24(12): 3279-3282, 2020 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-32955715

RESUMEN

COVID-19 has caused devastating health consequences and social inequities globally and in the United States. Unfortunately, the US has not developed a comprehensive National COVID-19 Strategy. In this editorial, we briefly review lessons about the development, structure, implementation and evaluation of the National HIV/AIDS Strategy (NHAS) for the US, and use these lessons to inform an initial proposal for a timely, dynamic, evidence-based, participatory, comprehensive and impactful National COVID-19 Strategy. Without such a strategy, the national response to the COVID-19 pandemic will remain uneven across jurisdictions and less than optimally impactful on disease-related mortality, short- and long-term morbidity, and health and social inequities.


Asunto(s)
Betacoronavirus , Infecciones por Coronavirus , Infecciones por VIH , Pandemias , Neumonía Viral , COVID-19 , Infecciones por Coronavirus/epidemiología , VIH , Infecciones por VIH/epidemiología , Infecciones por VIH/prevención & control , Humanos , Neumonía Viral/epidemiología , SARS-CoV-2 , Estados Unidos/epidemiología
8.
AIDS Behav ; 24(7): 1980-1982, 2020 07.
Artículo en Inglés | MEDLINE | ID: mdl-32274671
9.
Health Aff (Millwood) ; 39(4): 716, 2020 04.
Artículo en Inglés | MEDLINE | ID: mdl-32250686
10.
AIDS Behav ; 23(11): 2899-2903, 2019 11.
Artículo en Inglés | MEDLINE | ID: mdl-30953303
12.
J Homosex ; 66(5): 571-589, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-29297774

RESUMEN

LGBT (lesbian, gay, bisexual, and transgender) populations experience disparities in health outcomes, both physical and mental, compared to their heterosexual and cisgender peers. This commentary confronts the view held by some researchers that the disparate rates of mental health problems reported among LGBT populations are the consequences of pursuing a particular life trajectory, rather than resulting from the corrosive and persistent impact of stigma. Suggesting that mental health disparities among LGBT populations arise internally, de novo, when individuals express non-heterosexual and non-conforming gender identities ignores the vast body of evidence documenting the destructive impact of socially mediated stigma and systemic discrimination on health outcomes for a number of minorities, including sexual and gender minorities. Furthermore, such thinking is antithetical to widely accepted standards of health and wellbeing because it implies that LGBT persons should adopt and live out identities that contradict or deny their innermost feelings of self.


Asunto(s)
Disparidades en el Estado de Salud , Minorías Sexuales y de Género/psicología , Estigma Social , Femenino , Identidad de Género , Homosexualidad/psicología , Humanos , Masculino , Salud Mental , Distancia Psicológica
14.
AIDS Educ Prev ; 30(3): 187-198, 2018 06.
Artículo en Inglés | MEDLINE | ID: mdl-29969304

RESUMEN

Accelerating the fight against HIV globally and achieving the goals of the U.S. National HIV/AIDS Strategy will require an integrated health system that addresses all dimensions of wellness and is not limited to disease diagnosis and treatment or to monolithic prevention strategies. Since the HIV/AIDS epidemic was first recognized in 1981, HIV prevention strategies have evolved from early, information-based efforts to theory-informed and evidence-based approaches. More recently, the growing recognition that social and economic factors play a major role in shaping population health outcomes has driven HIV prevention and care programs in the direction of "people-centered health systems," as called for in the 2016 United Nations General Assembly declaration to end AIDS by 2030. This commentary examines recent innovations in HIV program design and implementation (e.g., using data in novel ways to improve HIV health outcomes, providing incentives to promote integrated HIV prevention and care, and developing mechanisms to proactively address the social determinants affecting health) that embrace a comprehensive vision of health that is much broader than the absence of detectable virus.


Asunto(s)
Prestación Integrada de Atención de Salud/organización & administración , Infecciones por VIH/prevención & control , Determinantes Sociales de la Salud , Accesibilidad a los Servicios de Salud , Humanos , Motivación , Atención Dirigida al Paciente
17.
AIDS Educ Prev ; 30(1): 26-34, 2018 02.
Artículo en Inglés | MEDLINE | ID: mdl-29481299

RESUMEN

The ability to depict surveillance and other complex health-related data in a visual manner promotes sound public health practice by supporting the three core functions of public health: assessment, policy development, and assurance. Further, such efforts potentiate the use of surveillance data beyond traditional public health audiences and venues, thus fostering a "culture of health." This practice report provides several recent examples of how data from AIDSVu-an interactive map of the U.S. showing the impact of HIV at national, state, and local levels-has been used to: fine tune the assessment of HIV-related disparities at a community level, educate and empower communities about HIV and its consequences, and better target HIV interventions to reach underserved, vulnerable populations.


Asunto(s)
Visualización de Datos , Infecciones por VIH/prevención & control , Formulación de Políticas , Vigilancia de la Población , Práctica de Salud Pública , Humanos , Salud Pública
19.
AIDS Behav ; 21(3): 611-614, 2017 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-28144791

RESUMEN

The November 2016 general election and subsequent voting of the Electoral College resulted in the selection of Donald Trump as President of the United States. The incoming Administration ran a campaign that indicated a desire for substantial change in health policy, including the repeal of the Affordable Care Act (ACA). President Trump has said very little directly about HIV programs and policies, but some campaign positions (such as the repeal of the ACA) would clearly and substantially impact the lives of persons living with HIV. In this editorial, we highlight important HIV-related goals to which we must recommit ourselves, and we underscore several key points about evidence-based advocacy that are important to revisit at any time (but most especially when there is a change in Administration).


Asunto(s)
Política de Salud , Patient Protection and Affordable Care Act , Política , Serodiagnóstico del SIDA , Infecciones por VIH , Humanos , Investigación Biomédica Traslacional , Estados Unidos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...